Female infertility in nonclassic congenital adrenal hyperplasia: beyond hyperandrogenism
- 1Reproductive Medicine Center, Children’s Hospital of Shanxi, Women Health Center of Shanxi, Affiliated Children’s Hospital of Shanxi Medical University, Taiyuan, Shanxi China
- 2Centre for Clinical Discipline Development, Shanxi Medical University, Taiyuan, Shanxi China
Abstract
Nonclassic congenital adrenal hyperplasia (NCCAH) is a common autosomal recessive endocrinopathy, primarily caused by partial 21-hydroxylase (CYP21A2) deficiency, and represents a significant but often underrecognized cause of female infertility. Clinically, affected women frequently present with hyperandrogenism, menstrual irregularities, and ovulatory dysfunction, which can lead to misdiagnosis as polycystic ovary syndrome (PCOS). Traditionally, reproductive failure in NCCAH has been attributed solely to androgen excess disrupting folliculogenesis. However, recent evidence reveals a multifactorial pathophysiology. Beyond hyperandrogenism, premature follicular-phase progesterone elevation, disruption of the hypothalamic–pituitary–ovarian (HPO) axis, impaired endometrial receptivity, and increased risk of early pregnancy loss collectively contribute to infertility. Accurate diagnosis requires a structured approach, including basal and adrenocorticotropic hormone (ACTH)-stimulated 17-hydroxyprogesterone (17-OHP) measurement, comprehensive endocrine profiling, and genetic testing. Therefore, fertility optimization should extend beyond isolated androgen suppression. This review critically summarizes current knowledge of NCCAH-related infertility mechanisms and proposes an integrated, multidisciplinary management strategy—encompassing targeted targeted glucocorticoid (GC) therapy, ovulation induction, assisted reproductive technology (ART), careful obstetric monitoring, and genetic counseling—to improve fertility and pregnancy outcomes in this patient population.
Related
- From Trauma to Tumour: Incidental Giant Left Adrenal Myelolipoma in Congenital Adrenal Hyperplasia
- Congenital adrenal hyperplasia combined with a huge adrenal myelolipoma of the unilateral adrenal gland in a 51-year-old female: a case report.
- A case report of osilodrostat treatment in primary bilateral macronodular adrenal hyperplasia associated with bilateral adrenal mass reduction.
- Pupillary signs are associated with subsequent Hirschsprung disease diagnosis and malignant adrenal neoplasm in congenital central hypoventilation syndrome
- Global estimates of infertility burden and contributions of congenital, endocrine, metabolic and infectious factors
BibTeX
@article{wang2026female,
title = {{Female infertility in nonclassic congenital adrenal hyperplasia: beyond hyperandrogenism}},
author = {Shimin Wang and Xinhong Li and Ningxin Zhang and Xiuping Zhang and Xueqing Wu},
journal = {Reproductive Biology and Endocrinology : RB\&E},
year = {2026},
month = aug,
doi = {10.1186/s12958-026-01603-3},
url = {https://doi.org/10.1186/s12958-026-01603-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Female infertility in nonclassic congenital adrenal hyperplasia: beyond hyperandrogenism
AU - Shimin Wang
AU - Xinhong Li
AU - Ningxin Zhang
AU - Xiuping Zhang
AU - Xueqing Wu
PY - 2026
DA - 2026/08/08
JO - Reproductive Biology and Endocrinology : RB&E
DO - 10.1186/s12958-026-01603-3
UR - https://doi.org/10.1186/s12958-026-01603-3
AB - Nonclassic congenital adrenal hyperplasia (NCCAH) is a common autosomal recessive endocrinopathy, primarily caused by partial 21-hydroxylase (CYP21A2) deficiency, and represents a significant but often underrecognized cause of female infertility. Clinically, affected women frequently present with hyperandrogenism, menstrual irregularities, and ovulatory dysfunction, which can lead to misdiagnosis as polycystic ovary syndrome (PCOS). Traditionally, reproductive failure in NCCAH has been attributed solely to androgen excess disrupting folliculogenesis. However, recent evidence reveals a multifactorial pathophysiology. Beyond hyperandrogenism, premature follicular-phase progesterone elevation, disruption of the hypothalamic–pituitary–ovarian (HPO) axis, impaired endometrial receptivity, and increased risk of early pregnancy loss collectively contribute to infertility. Accurate diagnosis requires a structured approach, including basal and adrenocorticotropic hormone (ACTH)-stimulated 17-hydroxyprogesterone (17-OHP) measurement, comprehensive endocrine profiling, and genetic testing. Therefore, fertility optimization should extend beyond isolated androgen suppression. This review critically summarizes current knowledge of NCCAH-related infertility mechanisms and proposes an integrated, multidisciplinary management strategy—encompassing targeted targeted glucocorticoid (GC) therapy, ovulation induction, assisted reproductive technology (ART), careful obstetric monitoring, and genetic counseling—to improve fertility and pregnancy outcomes in this patient population.
SN - 1477-7827
ER -